Speaker illustration

Doctor Ana Maria Merino Merino

University Hospital of Burgos, Burgos (Spain)

Member of:

Heart Failure Association

Atrial fibrillation and heart failure with non reduced ejection fraction: can biomarkers make the difference?

Event: Heart Failure 2019

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Galectin-3 as a new thrombotic risk factor in patients with atrial fibrillation

Event: EHRA 2019

Topic: Mechanisms for Stroke

Session: Atrial Fibrillation - Pathophysiology and Mechanisms

Thumbnail

Biomarkers in atrial fibrillation: novel red flags to keep in mind

Event: EHRA 2019

Topic: Atrial Stressors

Session: Atrial Fibrillation - Pathophysiology and Mechanisms

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb